Cargando…
The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells
Lithium salt is a classic glycogen synthase kinase 3 (GSK3) inhibitor. Beryllium is a structurally related inhibitor that is more potent but relatively uncharacterized. This study examined the effects of these inhibitors on the phosphorylation of endogenous GSK3 substrates. In NIH-3T3 cells, both sa...
Autores principales: | Abdul, Ata ur Rahman Mohammed, De Silva, Bhagya, Gary, Ronald K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829510/ https://www.ncbi.nlm.nih.gov/pubmed/29212798 http://dx.doi.org/10.1242/bio.030874 |
Ejemplares similares
-
Lithium and Therapeutic Targeting of GSK-3
por: Snitow, Melinda E., et al.
Publicado: (2021) -
AKT/GSK3β Signaling in Glioblastoma
por: Majewska, Ewelina, et al.
Publicado: (2016) -
What Are the bona fide GSK3 Substrates?
por: Sutherland, Calum
Publicado: (2011) -
GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions
por: Zhu, Huazhang, et al.
Publicado: (2018) -
GSK-3β and ERK1/2 incongruously act in tau hyperphosphorylation in SPS-induced PTSD rats
por: Wei, Zhen, et al.
Publicado: (2019)